If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

Researchers have discovered how a surface protein on brain cells, called Aplp1, can play a role in spreading material ...

Barely an hour after being wheeled into a clinical space at Oregon Health & Science University on Aug. 27, an Arkansas woman ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...

The world's largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments that can slow or halt ...

Scientists have achieved a significant breakthrough in Parkinson’s research, developing a novel technique that can detect tiny brain clusters believed to trigger the debilitating disease. A hallmark ...

For neurologist and movement disorder specialist Dr. Jill Giordano Farmer, the fight against Parkinson’s isn’t just ...

An estimated 1.1 million Americans are living with Parkinson’s disease (PD), making it the second most common neurodegenerative disease after Alzheimer’s. “Parkinson’s is a disease in which neurons ...

Scientists have developed a groundbreaking technique enabling them to visualise tiny brain clusters believed to trigger Parkinson’s disease. Researchers hailed the breakthrough, likening it to "being ...

Deep brain stimulation (DBS) is a surgical procedure that entails the delivery of high-frequency electrical impulses to ...

Parkinson's disease is fundamentally a breakdown in the functioning of a part of the brain called the basal ganglia, robbing ...